nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—AHR—Leflunomide—systemic scleroderma	0.761	0.938	CbGbCtD
Nimodipine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0295	0.0364	CbGbCtD
Nimodipine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0115	0.0142	CbGbCtD
Nimodipine—CYP3A4—Prednisone—systemic scleroderma	0.00921	0.0113	CbGbCtD
Nimodipine—CACNB4—tendon—systemic scleroderma	0.00216	0.0677	CbGeAlD
Nimodipine—CACNB4—lung—systemic scleroderma	0.0019	0.0594	CbGeAlD
Nimodipine—CACNA1S—tendon—systemic scleroderma	0.00185	0.058	CbGeAlD
Nimodipine—CACNB3—digestive system—systemic scleroderma	0.00174	0.0545	CbGeAlD
Nimodipine—CACNB1—tendon—systemic scleroderma	0.00173	0.0541	CbGeAlD
Nimodipine—CACNB3—tendon—systemic scleroderma	0.00166	0.0519	CbGeAlD
Nimodipine—AHR—smooth muscle tissue—systemic scleroderma	0.00163	0.0511	CbGeAlD
Nimodipine—CACNB3—lung—systemic scleroderma	0.00145	0.0455	CbGeAlD
Nimodipine—CACNA1C—connective tissue—systemic scleroderma	0.00131	0.0409	CbGeAlD
Nimodipine—AHR—digestive system—systemic scleroderma	0.00129	0.0404	CbGeAlD
Nimodipine—AHR—tendon—systemic scleroderma	0.00123	0.0384	CbGeAlD
Nimodipine—CACNA1C—smooth muscle tissue—systemic scleroderma	0.0012	0.0374	CbGeAlD
Nimodipine—NR3C2—connective tissue—systemic scleroderma	0.00119	0.0372	CbGeAlD
Nimodipine—CACNB2—digestive system—systemic scleroderma	0.00117	0.0366	CbGeAlD
Nimodipine—CACNB2—tendon—systemic scleroderma	0.00111	0.0349	CbGeAlD
Nimodipine—NR3C2—smooth muscle tissue—systemic scleroderma	0.00109	0.0341	CbGeAlD
Nimodipine—AHR—lung—systemic scleroderma	0.00108	0.0337	CbGeAlD
Nimodipine—CACNB2—lung—systemic scleroderma	0.000977	0.0306	CbGeAlD
Nimodipine—CACNA1C—digestive system—systemic scleroderma	0.000944	0.0295	CbGeAlD
Nimodipine—Gastrointestinal haemorrhage—Mycophenolic acid—systemic scleroderma	0.000881	0.00563	CcSEcCtD
Nimodipine—NR3C2—digestive system—systemic scleroderma	0.000859	0.0269	CbGeAlD
Nimodipine—Muscle spasms—Pentoxifylline—systemic scleroderma	0.000856	0.00547	CcSEcCtD
Nimodipine—CACNA1D—lung—systemic scleroderma	0.000854	0.0267	CbGeAlD
Nimodipine—Liver function test abnormal—Leflunomide—systemic scleroderma	0.000852	0.00545	CcSEcCtD
Nimodipine—Jaundice—Captopril—systemic scleroderma	0.000841	0.00538	CcSEcCtD
Nimodipine—Cramp muscle—Leflunomide—systemic scleroderma	0.000831	0.00531	CcSEcCtD
Nimodipine—Anaemia—Pentoxifylline—systemic scleroderma	0.000823	0.00526	CcSEcCtD
Nimodipine—NR3C2—tendon—systemic scleroderma	0.000818	0.0256	CbGeAlD
Nimodipine—Liver function test abnormal—Mycophenolic acid—systemic scleroderma	0.000813	0.0052	CcSEcCtD
Nimodipine—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.000807	0.00516	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Mycophenolate mofetil—systemic scleroderma	0.000799	0.00511	CcSEcCtD
Nimodipine—Immune system disorder—Mometasone—systemic scleroderma	0.000797	0.00509	CcSEcCtD
Nimodipine—Hyponatraemia—Lisinopril—systemic scleroderma	0.000796	0.00509	CcSEcCtD
Nimodipine—Cramp muscle—Mycophenolic acid—systemic scleroderma	0.000793	0.00507	CcSEcCtD
Nimodipine—CACNA1C—lung—systemic scleroderma	0.000789	0.0247	CbGeAlD
Nimodipine—Palpitations—Pentoxifylline—systemic scleroderma	0.000786	0.00503	CcSEcCtD
Nimodipine—Sweating increased—Leflunomide—systemic scleroderma	0.000777	0.00497	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.000777	0.00496	CcSEcCtD
Nimodipine—Hepatitis—Captopril—systemic scleroderma	0.000775	0.00495	CcSEcCtD
Nimodipine—Acne—Prednisone—systemic scleroderma	0.000771	0.00493	CcSEcCtD
Nimodipine—Hypertension—Pentoxifylline—systemic scleroderma	0.000768	0.00491	CcSEcCtD
Nimodipine—Cardiac failure congestive—Mycophenolate mofetil—systemic scleroderma	0.000766	0.0049	CcSEcCtD
Nimodipine—Myalgia—Pentoxifylline—systemic scleroderma	0.000758	0.00484	CcSEcCtD
Nimodipine—Oedema—Pentoxifylline—systemic scleroderma	0.000726	0.00464	CcSEcCtD
Nimodipine—Flushing—Captopril—systemic scleroderma	0.000719	0.0046	CcSEcCtD
Nimodipine—NR3C2—lung—systemic scleroderma	0.000718	0.0225	CbGeAlD
Nimodipine—Cramp muscle—Lisinopril—systemic scleroderma	0.000714	0.00457	CcSEcCtD
Nimodipine—Hepatobiliary disease—Azathioprine—systemic scleroderma	0.000712	0.00455	CcSEcCtD
Nimodipine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.000711	0.00455	CcSEcCtD
Nimodipine—Tachycardia—Pentoxifylline—systemic scleroderma	0.000709	0.00453	CcSEcCtD
Nimodipine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.000702	0.00449	CcSEcCtD
Nimodipine—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.000698	0.00446	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000695	0.00444	CcSEcCtD
Nimodipine—Jaundice—Leflunomide—systemic scleroderma	0.000693	0.00443	CcSEcCtD
Nimodipine—Hypotension—Pentoxifylline—systemic scleroderma	0.000679	0.00434	CcSEcCtD
Nimodipine—Hepatobiliary disease—Leflunomide—systemic scleroderma	0.000673	0.0043	CcSEcCtD
Nimodipine—Sweating increased—Lisinopril—systemic scleroderma	0.000668	0.00427	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.000662	0.00423	CcSEcCtD
Nimodipine—Jaundice—Mycophenolic acid—systemic scleroderma	0.000661	0.00423	CcSEcCtD
Nimodipine—Myalgia—Mometasone—systemic scleroderma	0.000654	0.00418	CcSEcCtD
Nimodipine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000648	0.00414	CcSEcCtD
Nimodipine—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.000642	0.0041	CcSEcCtD
Nimodipine—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.000642	0.0041	CcSEcCtD
Nimodipine—Hepatitis—Leflunomide—systemic scleroderma	0.000639	0.00408	CcSEcCtD
Nimodipine—Anaemia—Captopril—systemic scleroderma	0.000623	0.00398	CcSEcCtD
Nimodipine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00062	0.00396	CcSEcCtD
Nimodipine—Fluid retention—Prednisone—systemic scleroderma	0.000616	0.00394	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000613	0.00392	CcSEcCtD
Nimodipine—Immune system disorder—Azathioprine—systemic scleroderma	0.000611	0.0039	CcSEcCtD
Nimodipine—Depression—Lisinopril—systemic scleroderma	0.000609	0.0039	CcSEcCtD
Nimodipine—Hepatitis—Mycophenolic acid—systemic scleroderma	0.000609	0.00389	CcSEcCtD
Nimodipine—Palpitations—Captopril—systemic scleroderma	0.000596	0.00381	CcSEcCtD
Nimodipine—Jaundice—Lisinopril—systemic scleroderma	0.000596	0.00381	CcSEcCtD
Nimodipine—Cardiac disorder—Leflunomide—systemic scleroderma	0.000593	0.00379	CcSEcCtD
Nimodipine—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.000578	0.00369	CcSEcCtD
Nimodipine—Immune system disorder—Leflunomide—systemic scleroderma	0.000577	0.00369	CcSEcCtD
Nimodipine—Myalgia—Captopril—systemic scleroderma	0.000574	0.00367	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000571	0.00365	CcSEcCtD
Nimodipine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.000565	0.00361	CcSEcCtD
Nimodipine—Dyspnoea—Mometasone—systemic scleroderma	0.000559	0.00357	CcSEcCtD
Nimodipine—Bradycardia—Lisinopril—systemic scleroderma	0.000559	0.00357	CcSEcCtD
Nimodipine—Angiopathy—Mycophenolic acid—systemic scleroderma	0.000553	0.00353	CcSEcCtD
Nimodipine—Hepatitis—Lisinopril—systemic scleroderma	0.000549	0.00351	CcSEcCtD
Nimodipine—Anaemia—Azathioprine—systemic scleroderma	0.000544	0.00348	CcSEcCtD
Nimodipine—Thrombocytopenia—Captopril—systemic scleroderma	0.000539	0.00344	CcSEcCtD
Nimodipine—Tachycardia—Captopril—systemic scleroderma	0.000537	0.00343	CcSEcCtD
Nimodipine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000535	0.00342	CcSEcCtD
Nimodipine—Muscle spasms—Leflunomide—systemic scleroderma	0.000534	0.00342	CcSEcCtD
Nimodipine—Depression—Mycophenolate mofetil—systemic scleroderma	0.000534	0.00341	CcSEcCtD
Nimodipine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000522	0.00334	CcSEcCtD
Nimodipine—Cardiac failure congestive—Prednisone—systemic scleroderma	0.000519	0.00332	CcSEcCtD
Nimodipine—Hypotension—Captopril—systemic scleroderma	0.000514	0.00329	CcSEcCtD
Nimodipine—Pruritus—Pentoxifylline—systemic scleroderma	0.000514	0.00328	CcSEcCtD
Nimodipine—Anaemia—Leflunomide—systemic scleroderma	0.000514	0.00328	CcSEcCtD
Nimodipine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00051	0.00326	CcSEcCtD
Nimodipine—Flushing—Lisinopril—systemic scleroderma	0.000509	0.00325	CcSEcCtD
Nimodipine—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00324	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000502	0.00321	CcSEcCtD
Nimodipine—Myalgia—Azathioprine—systemic scleroderma	0.000501	0.0032	CcSEcCtD
Nimodipine—Angiopathy—Lisinopril—systemic scleroderma	0.000498	0.00318	CcSEcCtD
Nimodipine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000497	0.00318	CcSEcCtD
Nimodipine—Palpitations—Leflunomide—systemic scleroderma	0.000491	0.00314	CcSEcCtD
Nimodipine—Dyspnoea—Captopril—systemic scleroderma	0.000491	0.00314	CcSEcCtD
Nimodipine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00049	0.00313	CcSEcCtD
Nimodipine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000489	0.00313	CcSEcCtD
Nimodipine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00307	CcSEcCtD
Nimodipine—Dizziness—Pentoxifylline—systemic scleroderma	0.00048	0.00307	CcSEcCtD
Nimodipine—Hypertension—Leflunomide—systemic scleroderma	0.00048	0.00307	CcSEcCtD
Nimodipine—Myalgia—Leflunomide—systemic scleroderma	0.000473	0.00302	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000471	0.00301	CcSEcCtD
Nimodipine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00047	0.00301	CcSEcCtD
Nimodipine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000469	0.003	CcSEcCtD
Nimodipine—CYP3A5—digestive system—systemic scleroderma	0.000465	0.0145	CbGeAlD
Nimodipine—Vomiting—Pentoxifylline—systemic scleroderma	0.000462	0.00295	CcSEcCtD
Nimodipine—Muscle spasms—Lisinopril—systemic scleroderma	0.000459	0.00294	CcSEcCtD
Nimodipine—Rash—Pentoxifylline—systemic scleroderma	0.000458	0.00293	CcSEcCtD
Nimodipine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000458	0.00293	CcSEcCtD
Nimodipine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000458	0.00292	CcSEcCtD
Nimodipine—Headache—Pentoxifylline—systemic scleroderma	0.000455	0.00291	CcSEcCtD
Nimodipine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000451	0.00289	CcSEcCtD
Nimodipine—Hypotension—Azathioprine—systemic scleroderma	0.000449	0.00287	CcSEcCtD
Nimodipine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000446	0.00285	CcSEcCtD
Nimodipine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000445	0.00284	CcSEcCtD
Nimodipine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000444	0.00284	CcSEcCtD
Nimodipine—Pruritus—Mometasone—systemic scleroderma	0.000443	0.00283	CcSEcCtD
Nimodipine—Tachycardia—Leflunomide—systemic scleroderma	0.000443	0.00283	CcSEcCtD
Nimodipine—Anaemia—Lisinopril—systemic scleroderma	0.000441	0.00282	CcSEcCtD
Nimodipine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000439	0.0028	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000438	0.0028	CcSEcCtD
Nimodipine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000436	0.00279	CcSEcCtD
Nimodipine—Oedema—Mycophenolic acid—systemic scleroderma	0.000433	0.00277	CcSEcCtD
Nimodipine—Nausea—Pentoxifylline—systemic scleroderma	0.000431	0.00276	CcSEcCtD
Nimodipine—Diarrhoea—Mometasone—systemic scleroderma	0.000429	0.00274	CcSEcCtD
Nimodipine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000424	0.00271	CcSEcCtD
Nimodipine—Hypotension—Leflunomide—systemic scleroderma	0.000424	0.00271	CcSEcCtD
Nimodipine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000424	0.00271	CcSEcCtD
Nimodipine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000422	0.0027	CcSEcCtD
Nimodipine—Palpitations—Lisinopril—systemic scleroderma	0.000422	0.0027	CcSEcCtD
Nimodipine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000418	0.00267	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000415	0.00266	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000415	0.00265	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000413	0.00264	CcSEcCtD
Nimodipine—Myalgia—Lisinopril—systemic scleroderma	0.000407	0.0026	CcSEcCtD
Nimodipine—Dyspnoea—Leflunomide—systemic scleroderma	0.000404	0.00259	CcSEcCtD
Nimodipine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000404	0.00258	CcSEcCtD
Nimodipine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00257	CcSEcCtD
Nimodipine—Vomiting—Mometasone—systemic scleroderma	0.000398	0.00255	CcSEcCtD
Nimodipine—Sweating increased—Prednisone—systemic scleroderma	0.000397	0.00253	CcSEcCtD
Nimodipine—Rash—Mometasone—systemic scleroderma	0.000395	0.00253	CcSEcCtD
Nimodipine—Dermatitis—Mometasone—systemic scleroderma	0.000395	0.00252	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000394	0.00252	CcSEcCtD
Nimodipine—Headache—Mometasone—systemic scleroderma	0.000393	0.00251	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000392	0.0025	CcSEcCtD
Nimodipine—Oedema—Lisinopril—systemic scleroderma	0.00039	0.00249	CcSEcCtD
Nimodipine—Pruritus—Captopril—systemic scleroderma	0.000389	0.00249	CcSEcCtD
Nimodipine—CYP3A5—lung—systemic scleroderma	0.000388	0.0121	CbGeAlD
Nimodipine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000387	0.00247	CcSEcCtD
Nimodipine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000386	0.00247	CcSEcCtD
Nimodipine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000382	0.00244	CcSEcCtD
Nimodipine—Tachycardia—Lisinopril—systemic scleroderma	0.00038	0.00243	CcSEcCtD
Nimodipine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000377	0.00241	CcSEcCtD
Nimodipine—Diarrhoea—Captopril—systemic scleroderma	0.000377	0.00241	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000374	0.00239	CcSEcCtD
Nimodipine—Nausea—Mometasone—systemic scleroderma	0.000372	0.00238	CcSEcCtD
Nimodipine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00236	CcSEcCtD
Nimodipine—Hypotension—Lisinopril—systemic scleroderma	0.000364	0.00233	CcSEcCtD
Nimodipine—Dizziness—Captopril—systemic scleroderma	0.000364	0.00233	CcSEcCtD
Nimodipine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000363	0.00232	CcSEcCtD
Nimodipine—Depression—Prednisone—systemic scleroderma	0.000362	0.00231	CcSEcCtD
Nimodipine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00231	CcSEcCtD
Nimodipine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000356	0.00228	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000355	0.00227	CcSEcCtD
Nimodipine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000354	0.00226	CcSEcCtD
Nimodipine—Vomiting—Captopril—systemic scleroderma	0.00035	0.00224	CcSEcCtD
Nimodipine—CYP3A4—digestive system—systemic scleroderma	0.000349	0.0109	CbGeAlD
Nimodipine—Dyspnoea—Lisinopril—systemic scleroderma	0.000348	0.00222	CcSEcCtD
Nimodipine—Rash—Captopril—systemic scleroderma	0.000347	0.00222	CcSEcCtD
Nimodipine—Dermatitis—Captopril—systemic scleroderma	0.000347	0.00222	CcSEcCtD
Nimodipine—Headache—Captopril—systemic scleroderma	0.000345	0.0022	CcSEcCtD
Nimodipine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00218	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000337	0.00215	CcSEcCtD
Nimodipine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000335	0.00214	CcSEcCtD
Nimodipine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00214	CcSEcCtD
Nimodipine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000334	0.00214	CcSEcCtD
Nimodipine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00213	CcSEcCtD
Nimodipine—Bradycardia—Prednisone—systemic scleroderma	0.000332	0.00212	CcSEcCtD
Nimodipine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00211	CcSEcCtD
Nimodipine—Diarrhoea—Azathioprine—systemic scleroderma	0.000329	0.0021	CcSEcCtD
Nimodipine—Nausea—Captopril—systemic scleroderma	0.000327	0.00209	CcSEcCtD
Nimodipine—Pruritus—Leflunomide—systemic scleroderma	0.000321	0.00205	CcSEcCtD
Nimodipine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000319	0.00204	CcSEcCtD
Nimodipine—Dizziness—Azathioprine—systemic scleroderma	0.000318	0.00203	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000311	0.00199	CcSEcCtD
Nimodipine—Diarrhoea—Leflunomide—systemic scleroderma	0.00031	0.00198	CcSEcCtD
Nimodipine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000306	0.00196	CcSEcCtD
Nimodipine—Vomiting—Azathioprine—systemic scleroderma	0.000305	0.00195	CcSEcCtD
Nimodipine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00195	CcSEcCtD
Nimodipine—Rash—Azathioprine—systemic scleroderma	0.000303	0.00194	CcSEcCtD
Nimodipine—Dermatitis—Azathioprine—systemic scleroderma	0.000303	0.00193	CcSEcCtD
Nimodipine—Depression—Methotrexate—systemic scleroderma	0.000303	0.00193	CcSEcCtD
Nimodipine—Flushing—Prednisone—systemic scleroderma	0.000302	0.00193	CcSEcCtD
Nimodipine—Headache—Azathioprine—systemic scleroderma	0.000301	0.00192	CcSEcCtD
Nimodipine—Dizziness—Leflunomide—systemic scleroderma	0.0003	0.00192	CcSEcCtD
Nimodipine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000296	0.00189	CcSEcCtD
Nimodipine—Angiopathy—Prednisone—systemic scleroderma	0.000296	0.00189	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00188	CcSEcCtD
Nimodipine—Immune system disorder—Prednisone—systemic scleroderma	0.000294	0.00188	CcSEcCtD
Nimodipine—Vomiting—Leflunomide—systemic scleroderma	0.000288	0.00184	CcSEcCtD
Nimodipine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000287	0.00184	CcSEcCtD
Nimodipine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000287	0.00183	CcSEcCtD
Nimodipine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000286	0.00183	CcSEcCtD
Nimodipine—Rash—Leflunomide—systemic scleroderma	0.000286	0.00183	CcSEcCtD
Nimodipine—Dermatitis—Leflunomide—systemic scleroderma	0.000286	0.00183	CcSEcCtD
Nimodipine—Nausea—Azathioprine—systemic scleroderma	0.000285	0.00182	CcSEcCtD
Nimodipine—Headache—Leflunomide—systemic scleroderma	0.000284	0.00182	CcSEcCtD
Nimodipine—Pruritus—Lisinopril—systemic scleroderma	0.000276	0.00176	CcSEcCtD
Nimodipine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000275	0.00176	CcSEcCtD
Nimodipine—Rash—Mycophenolic acid—systemic scleroderma	0.000273	0.00174	CcSEcCtD
Nimodipine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000273	0.00174	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—systemic scleroderma	0.000272	0.00174	CcSEcCtD
Nimodipine—Headache—Mycophenolic acid—systemic scleroderma	0.000271	0.00173	CcSEcCtD
Nimodipine—Nausea—Leflunomide—systemic scleroderma	0.000269	0.00172	CcSEcCtD
Nimodipine—Diarrhoea—Lisinopril—systemic scleroderma	0.000267	0.0017	CcSEcCtD
Nimodipine—Anaemia—Prednisone—systemic scleroderma	0.000262	0.00168	CcSEcCtD
Nimodipine—Dizziness—Lisinopril—systemic scleroderma	0.000258	0.00165	CcSEcCtD
Nimodipine—Nausea—Mycophenolic acid—systemic scleroderma	0.000257	0.00164	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000253	0.00162	CcSEcCtD
Nimodipine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00161	CcSEcCtD
Nimodipine—Vomiting—Lisinopril—systemic scleroderma	0.000248	0.00158	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—systemic scleroderma	0.000247	0.00158	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—systemic scleroderma	0.000246	0.00157	CcSEcCtD
Nimodipine—Rash—Lisinopril—systemic scleroderma	0.000246	0.00157	CcSEcCtD
Nimodipine—Dermatitis—Lisinopril—systemic scleroderma	0.000246	0.00157	CcSEcCtD
Nimodipine—Hypertension—Prednisone—systemic scleroderma	0.000245	0.00157	CcSEcCtD
Nimodipine—Headache—Lisinopril—systemic scleroderma	0.000244	0.00156	CcSEcCtD
Nimodipine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000242	0.00154	CcSEcCtD
Nimodipine—Myalgia—Prednisone—systemic scleroderma	0.000242	0.00154	CcSEcCtD
Nimodipine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000234	0.00149	CcSEcCtD
Nimodipine—Nausea—Lisinopril—systemic scleroderma	0.000232	0.00148	CcSEcCtD
Nimodipine—Oedema—Prednisone—systemic scleroderma	0.000232	0.00148	CcSEcCtD
Nimodipine—Nervous system disorder—Prednisone—systemic scleroderma	0.000227	0.00145	CcSEcCtD
Nimodipine—Tachycardia—Prednisone—systemic scleroderma	0.000226	0.00144	CcSEcCtD
Nimodipine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000226	0.00144	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000224	0.00143	CcSEcCtD
Nimodipine—Anaemia—Methotrexate—systemic scleroderma	0.000219	0.0014	CcSEcCtD
Nimodipine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00139	CcSEcCtD
Nimodipine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000215	0.00138	CcSEcCtD
Nimodipine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000215	0.00138	CcSEcCtD
Nimodipine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000214	0.00137	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000211	0.00135	CcSEcCtD
Nimodipine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000203	0.0013	CcSEcCtD
Nimodipine—Myalgia—Methotrexate—systemic scleroderma	0.000202	0.00129	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00019	0.00121	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000189	0.00121	CcSEcCtD
Nimodipine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000187	0.0012	CcSEcCtD
Nimodipine—Hypotension—Methotrexate—systemic scleroderma	0.000181	0.00116	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000176	0.00113	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—systemic scleroderma	0.000173	0.0011	CcSEcCtD
Nimodipine—Hypersensitivity—Prednisone—systemic scleroderma	0.000171	0.00109	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000167	0.00107	CcSEcCtD
Nimodipine—Pruritus—Prednisone—systemic scleroderma	0.000164	0.00105	CcSEcCtD
Nimodipine—Diarrhoea—Prednisone—systemic scleroderma	0.000158	0.00101	CcSEcCtD
Nimodipine—Dizziness—Prednisone—systemic scleroderma	0.000153	0.000979	CcSEcCtD
Nimodipine—Vomiting—Prednisone—systemic scleroderma	0.000147	0.000941	CcSEcCtD
Nimodipine—Rash—Prednisone—systemic scleroderma	0.000146	0.000933	CcSEcCtD
Nimodipine—Dermatitis—Prednisone—systemic scleroderma	0.000146	0.000932	CcSEcCtD
Nimodipine—Headache—Prednisone—systemic scleroderma	0.000145	0.000927	CcSEcCtD
Nimodipine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000143	0.000911	CcSEcCtD
Nimodipine—Nausea—Prednisone—systemic scleroderma	0.000138	0.000879	CcSEcCtD
Nimodipine—Pruritus—Methotrexate—systemic scleroderma	0.000137	0.000875	CcSEcCtD
Nimodipine—Diarrhoea—Methotrexate—systemic scleroderma	0.000132	0.000846	CcSEcCtD
Nimodipine—Dizziness—Methotrexate—systemic scleroderma	0.000128	0.000818	CcSEcCtD
Nimodipine—Vomiting—Methotrexate—systemic scleroderma	0.000123	0.000786	CcSEcCtD
Nimodipine—Rash—Methotrexate—systemic scleroderma	0.000122	0.00078	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—systemic scleroderma	0.000122	0.000779	CcSEcCtD
Nimodipine—Headache—Methotrexate—systemic scleroderma	0.000121	0.000775	CcSEcCtD
Nimodipine—Nausea—Methotrexate—systemic scleroderma	0.000115	0.000735	CcSEcCtD
